GOSS · Gossamer Bio, Inc. · Congressional Trades
$11.50
+0.07 (+0.61%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company has concluded that these circumstances and the uncertainties associated with the Company’s ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$68.69M
Shares
6.12M
Volume · Nov 19
143.82K
Avg daily vol (50 sessions)
251.05K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1728117
CUSIP
38341P201
13F (30d)
100 filings
75 filers
Visit website
Investor relations